loader2
Partner With Us NRI

Advanced Enzyme Technologies Ltd share Price Today

Company details

419.90
433.65
291.10
441.95
6M Return 4.52%
1Y Return 28.55%
Mkt Cap.(Cr) 4,793.89
Volume 222,248
Div Yield 1.19%
OI
-
OI Chg %
-
Volume 222,248

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Biotechnology company Advanced Enzyme Technologies announced Q1FY25 results:

  • Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 1,545 million in the Q1FY25 from Rs 1,473 million in the Q1FY24, a growth of 5%. 
  • Profit: Consolidated EBITDA during Q1FY25 stands at Rs 512 million as compared to Rs 440 million during Q1FY24, an increase of 16%.
  • Profit before tax stands at Rs 487 million during Q1FY25 as against Rs 414 million in Q1FY24, an increase of 18%.
  • Profit after tax grew by 19% and stands at Rs 350 million during Q1FY25 as compared to Rs 294 million during the Q1FY24.
  • Margin: EBITDA margin stands at 33%, PBT margin stands at 31% and PAT margin stands at 23%
  • during the quarter.
  • Financial Costs: Financial costs stood at Rs 9 million during Q1FY25 as against Rs 7 million in Q1FY24.
  • Depreciation and Amortization: Depreciation and Amortization charge for the Q1FY25 remain unchanged at Rs 86 million as compared to the same quarter previous year. 
  • Earnings Per Share: Earnings Per Share during Q1FY25 stands at Rs 3.05 as compared to Rs 2.58 in Q1FY24.

Result PDF

View Other Company Results

Advanced Enzyme Technologies Ltd shares SWOT Analysis

Strengths (9)

  • MACD Crossover Above Signal Line
  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (1)

  • Declining Revenue every quarter for the past 2 quarters

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects

Resistance and support

R1 434.9
R2 441.2
R3 448.7
Pivot

427.42

S1 421.2
S2 413.7
S3 407.4
EMA SMA
410.8
396.6
385.9
369.6
408.9
390.4
381.0
371.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MOTILAL OSWAL FINANCIAL SERVICES LIMITED Bulk Purchase 2024-06-19 385 11053245 NSE
ORBIMED ASIA III MAURITIUS LIMITED Bulk Sell 2024-06-19 385 11053245 NSE
MOTILAL OSWAL FINANCIAL SERVICES LIMITED Block Purchase 2024-06-19 385 11053245 NSE
Name Category Shares
Kishor Laxminarayan Rathi PROMOTER 1.31%
Madhusudan Kabra PROMOTER 0.64%
Vasant Rathi PROMOTER 33.14%
Rasika Vasant Rathi PROMOTER 2.38%
Reshma Namita Rathi PROMOTER 2.37%
Rachana Vasant Rathi PROMOTER 2.36%
Prabhavati Vasant Rathi PROMOTER 0.82%

OUR RESEARCH VIEW

Investment recommendation
Good recovery in FY24; momentum likely to persist…
Call Date
17 May 2024
Entry Price 375.00
Target Price 470.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Advanced Enzyme Technologies Ltd Stocks COMPARISON

Financials( in Cr) Advanced Enzyme Technologies Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 428.70 1,742.75 1,576.10 4,633.90 1,187.55
% Change 0.36 0.06 0.79 -0.60 1.46
Mcap Cr 4,793.89 418,144.11 127,272.91 123,015.68 119,495.32
Revenue TTM Cr 623.87 48,496.85 25,774.09 7,845.00 19,547.40
Net Profit TTM Cr 136.95 9,648.44 4,155.31 1,600.00 3,854.40
PE TTM 32.11 39.62 28.43 73.92 28.26
1 Year Return 28.55 53.65 27.56 24.21 85.08
ROCE 14.53 17.20 22.27 16.41 23.94
ROE 10.70 16.13 16.58 12.15 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,324.13 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 37,516.17 -14,555.25
LAST 3M 90,902.40 37,557.41
LAST 6M 198,345.87 43,710.77
LAST 12M 329,168.77 54,053.10
Advanced Enzyme Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Aug 14, 2024 l NSE Announcement

Advanced Enzyme Technologies Limited - Copy of Newspaper Publication

Aug 13, 2024 l NSE Announcement

Advanced Enzyme Technologies Limited - Outcome of Board Meeting

Aug 12, 2024 l NSE Announcement

Date Action Type Ratio
Jul 18, 2024 Dividend 55
May 17, 2024 Dividend 200
Aug 04, 2023 Dividend 50

Advanced Enzyme Technologies Ltd Information

Stock PE (TTM)
32.11
Promoter Holding
43.02%
Book Value
118.4117
ROCE
14.53%
ROE
10.7%
Description
  • Advanced Enzyme Technologies Limited is a manufacturing enzymes sector company having a market capitalization of is 5,100.96 Crores as of 15-May-2021. The company was incorporated in 1945. The company has reported its consolidated quarterly revenue of Rs. 139.09 Cr. at the end of December 2020. The company is found listed on the Bombay Stock Exchange (BSE) with the code 540025 and also listed on National Stock Exchange (NSE) with the symbol ADVENZYMES. Advanced Enzymes is the largest Indian enzyme company engaged in the research and development dedicated to marketing eco-safe solutions to a wide variety of industries like Pharmaceuticals, Baking, Agriculture, Waste Management, Textile, Leather, Distilling, Grain Processing, Juice Processing, etc, developed from over 65 indigenous enzymes & probiotics. As of March 31, 2020, the Company has 6 (six) direct subsidiaries and 5 (five) step-down subsidiaries. Out of which 3 (three) are Indian subsidiaries and 8 (eight) are foreign subsidiaries make a strong presence across 45 countries worldwide. With exports across 6 continents, they provide customized and effective enzyme solutions coupled with the best in technical advice and superior service. 20 patents. The company has granted more than 20 patents, currently having more than 550 employees, more than 25 years of fragmentation experience. The current fragmentation capacity of AETL is 470 m³. To strength, its product, Company spending on R & D as a percentage of turnover is increasing from past 4 years( As per March 2020, R & D cost to total turnover is 4.95%) Advanced Enzyme Technologies Limited (AETL) is having is earning 43% revenue from India and 57% revenue internationally. ATL is having high TTM EPS growth with Low debt. For F.Y 19-20. Annual net profits and Book value per share also increasing for the past 2 years. ATL is a company having zero promoter pledges and Strong cash-generating ability from its core business. As on 31-March 20, AETL is a company having zero promoter pledge and Strong cash-generating ability from core business.

Registered Address

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Tel : 91-22-41703200
Email : sanjay:advancedenzymes.com; info:advancedenzymes.c
Website : http://www.advancedenzymes.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
NSE Code : ADVENZYMES
Book Closure Date (Month) :
BSE Group : B
ISIN : INE837H01020

FAQ’s on Advanced Enzyme Technologies Ltd Shares

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Aug 16, 2024 03:55 PM the closing price of Advanced Enzyme Technologies Ltd was Rs.428.70.

The latest PE ratio of Advanced Enzyme Technologies Ltd as of Aug 16, 2024 03:55 PM is 32.11

The latest PB ratio of Advanced Enzyme Technologies Ltd as of Aug 16, 2024 03:55 PM is 0.28

The 52-week high of Advanced Enzyme Technologies Ltd share price is Rs. 441.95 while the 52-week low is Rs. 291.10

According to analyst recommendations, Advanced Enzyme Technologies Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Aug 16, 2024 03:55 PM, the market cap of Advanced Enzyme Technologies Ltd stood at Rs. 4,793.89 Cr.

Download App

Download Our App

Play Store App Store
market app